2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Peripheral Nervous System Neoplasms: new trials by email Literature Review of Peripheral Nervous System Neoplasms trials Research Report on Peripheral Nervous System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma Selinexor, Ixazomib - Liposarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 1 | Withdrawn | Matthew Ingham | 2020-11-01 | 2020-11-27 | |
| Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment talotrexin, chemotherapy - Brain and Central Nervous System Tumors, Leukemia | Phase 1 | Withdrawn | Children's Oncology Group | 2007-02-01 | 2014-08-08 |
Astrocytoma (1) · Burkitt Lymphoma (1) · Central Nervous System Neoplasms (1) · Choroid Plexus Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Familial ependymoma (1) · Leukemia (1) · Leukemia, Myelomonocytic, Juvenile (1) · Liposarcoma (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Medulloblastoma (1) · Neurofibrosarcoma (1) · Optic Nerve Glioma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Nerve Tissue (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Bone Marrow Diseases (1) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Cerebral Ventricle Neoplasms (1) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1) · DNA Virus Infections (1) · Disease Attributes (1)
Drug Therapy (1) · N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (1) · ixazomib (1) · selinexor (1)
Children's Oncology Group (1) · Matthew Ingham (1)
United States (1)
James Croop, MD, PhD (1) · Matthew Ingham, MD (1) · Sultan Ahmed Pradhan, MD (1)